Cardinal Health stock rises 1.22% and outperforms competitors
Updated
Updated · MarketWatch · May 1
Cardinal Health stock rises 1.22% and outperforms competitors
11 articles · Updated · MarketWatch · May 1
Shares closed at $195.24 on Friday, beating Amazon's 1.21% gain while UnitedHealth fell 0.46% and CVS dropped 1.44%.
The advance came in a mixed US market, with the S&P 500 up 0.29% to 7,230.12 and the Dow Jones Industrial Average down 0.31% to 49,499.27.
The gain ended a two-day losing streak, though the stock remains 16.42% below its 52-week high of $233.60 reached on 2 March. Trading volume of 2.1 million topped its 50-day average.
As new drug price laws squeeze margins, can Cardinal Health's pivot to specialty services actually fuel future growth?
With GAAP profits plunging 30%, is Cardinal Health's celebrated earnings beat hiding deeper operational problems?
Can Cardinal Health's nuclear medicine and AI bets create a defensible moat against its 'Big Three' competitors?